India's Alkem Labs' shares fall on row over fudging trial data

MUMBAI (Reuters) - Shares in India's Alkem Laboratories Ltd fell as much as 8 percent on Monday after the company confirmed it was in talks with German authorities who had accused it of fudging data in some clinical trials.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro